What F18 covers · when clinicians use it
ICD-10 code F18 identifies Inhalant related disorders in the U.S. ICD-10-CM clinical and billing record set. It sits within the Mental, Behavioral & Neurodevelopmental chapter (F01–F99), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply F18 when an encounter's findings match the Inhalant related disorders description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify F18 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for F18 and is a coding reference, not clinical, diagnostic, or billing advice.
F18 refers to Inhalant related disorders, a category of substance use disorders resulting from the repeated use of psychoactive drugs. These conditions may include dependence, abuse, intoxication, withdrawal symptoms, and associated mental or physical health complications.
Symptoms
- Cravings and compulsive use – Central to substance use disorders
- Withdrawal symptoms – Anxiety, tremors, nausea, or seizures when not using
- Loss of control – Inability to stop or reduce substance use
- Neglect of responsibilities – At home, school, or work
- Mood changes or irritability – Linked to intoxication or withdrawal
- Risky behaviors – Such as driving under influence or unsafe sex
- Tolerance – Needing higher doses to achieve the same effect
Diagnosis
Diagnosis of Inhalant related disorders involves a detailed clinical history, DSM-5 criteria evaluation, toxicology screening, physical exam, and mental health assessments. Severity is often categorized as mild, moderate, or severe based on behavioral and physiological patterns.
ICD10 Code Usage
ICD10 code F18 is widely used in psychiatry, addiction medicine, emergency care, and primary care. It supports treatment planning, billing for detox or rehab, reporting to public health registries, and long-term behavioral health tracking.
Related Codes
- F10 – Alcohol related disorders
- F11 – Opioid related disorders
- F12 – Cannabis related disorders
- F13 – Sedative, hypnotic, or anxiolytic related disorders
- F14 – Cocaine related disorders
- F15 – Other stimulant related disorders
- F16 – Hallucinogen related disorders
- F17 – Nicotine dependence
- F19 – Other psychoactive substance related disorders
FAQs
Q1: What is ICD10 code F18?
A: It refers to Inhalant related disorders, a substance use or dependence disorder caused by a specific psychoactive substance.
Q2: How are these conditions treated?
A: Through behavioral therapy, medication-assisted treatment (e.g., methadone, buprenorphine), detox, counseling, and support groups.
Q3: Are these conditions chronic?
A: Substance use disorders can be chronic and relapsing but are manageable with comprehensive care and support.
Q4: What is the role of medication?
A: Some disorders (e.g., F11 or F17) benefit from medications that reduce cravings or block effects of the drug.
Q5: Who manages these disorders?
A: Addiction specialists, psychiatrists, primary care providers, and counselors in inpatient or outpatient settings.
Conclusion
ICD10 code F18 is essential for diagnosing and managing Inhalant related disorders, ensuring patients receive appropriate addiction care, coverage for treatment services, and consistent tracking of recovery or relapse patterns over time.